CBD Oil Guide for NC: Types, Dosing & What to Buy

CBD oil is the most widely available hemp product in North Carolina and the easiest entry point for new consumers. Unlike THCa flower or Delta-8, CBD is non-intoxicating, it won't get you high. But the market is flooded with low-quality products, confusing labels, and unsubstantiated health claims that make it hard to know what you're actually buying.

This guide covers the three types of CBD, what the clinical research actually shows, how to dose, which medications interact with CBD, and how to find quality products at Triangle dispensaries.

The Three Types of CBD

Not all CBD products are the same. The type determines what else is in the product besides CBD, and that matters for effects, drug test risk, and legal status.

Which type should you choose?

• Full-spectrum if you want maximum potential benefit and aren't drug tested. The "entourage effect" theory suggests cannabinoids work better together, though human clinical evidence is still mixed.
• Broad-spectrum if you want some entourage benefits without THC. Good middle ground, but verify the COA: in one study, 26% of typed products didn't match their stated type, and 3 of 28 broad-spectrum products still contained THC (Frontiers in Pharmacology, 2024).
• Isolate if you're drug tested or want precise CBD dosing without other compounds. See our drug testing guide for why this matters.

Bioavailability: Why How You Take CBD Matters

Most people swallow CBD oil, but here's the problem: oral CBD has only 6–14% bioavailability. That means if you swallow a 50mg dose, your body absorbs just 3–7mg (PMC, 2024).

Practical tips to improve absorption:

• Holding oil under your tongue for 60–90 seconds is common advice, but a 2024 review found CBD crosses the lining of the mouth so slowly that most "sublingual" CBD is probably absorbed by swallowing anyway. It does no harm, but don't count on it to boost absorption.
• Take CBD oil with food, especially fatty food. CBD is fat-soluble. Epidiolex studies showed food increased absorption 4–5x compared to fasting.
• Nano-emulsion products (marketed as "water-soluble CBD") use smaller particle sizes to improve bioavailability. Brands market faster onset for these beverages, but those are marketing claims rather than trial results.

How to Dose CBD

There are no FDA-approved dosing guidelines for over-the-counter CBD products. Clinical studies have used doses ranging from 10mg to 1,500mg daily. For anxiety, lab and single-dose studies suggest an inverted U-shaped dose-response, where a middle dose (around 300mg) may work better than lower or higher ones; that pattern comes mostly from preclinical work (PMC, 2024).

For most consumers, the practical approach is:

Start low: 10–25mg per day, taken in 1–2 doses

Increase gradually: Add 5–10mg every 3–5 days until you notice effects

Track your response: Keep a simple log of dose, time, and how you feel

Reading CBD labels

The most important numbers on a CBD product label:

• Total CBD per bottle (e.g., 1,000mg), this is the total for the entire product
• CBD per serving (e.g., 33mg per 1mL dropper), this is what you're taking per dose
• CBD per mL or per unit, the concentration that determines value
• Type (full-spectrum, broad-spectrum, isolate), confirmed by COA, not just the label

Cost math: divide the price by the total CBD in the bottle. A 30mL tincture with 1,000mg CBD at $60 works out to $0.06 per mg, which makes it easy to compare bottles of different sizes. For more on evaluating product quality, see our COA reading guide.

What Does the Research Actually Show?

CBD has real clinical evidence for some uses, limited evidence for others, and no evidence for many claims made by brands. Here's what the peer-reviewed research says as of 2026:

Anxiety: Most promising, still early

A 2024 meta-analysis of 8 studies (316 participants) found a substantial effect size (Hedges' g = -0.92) for CBD reducing anxiety symptoms, though the authors caution that the samples were small (PubMed, 2024). A separate RCT (n=178) using nanodispersible CBD found significant reductions in both GAD-7 and HAM-A anxiety scores compared to placebo (ScienceDirect, 2024).

However, a systematic review of 15 RCTs found that 60% of studies showed single-dose CBD did NOT reduce anxiety, suggesting that consistent, multi-day dosing may be more effective than one-time use (PMC, 2024).

Pain: Promising but limited

A 2024 systematic review of 40 studies (11 human clinical trials) found that 7 of 11 human trials showed positive pain-reducing effects (PMC, 2024). Neuropathic pain has the most clinical data, though effects are modest and mostly involve THC-containing products; topical CBD for osteoarthritis is early and unconfirmed. However, the most authoritative 2025 AHRQ Living Systematic Review found that oral CBD alone "may not be associated with improved pain" versus placebo (NCBI, 2025), combination CBD+THC products showed better outcomes.

For a deeper dive, see our CBD for pain relief guide.

Sleep: Mixed

A clinical trial of 150mg CBD nightly showed results similar to placebo on most sleep outcomes, but CBD did improve objective sleep efficiency after 2 weeks and produced greater well-being scores (JCSM, 2024). A small 20-person pilot of a CBD, CBN and low-dose THC softgel reported better sleep quality (PMC, 2025).

The only FDA-approved CBD

Epidiolex is the only FDA-approved CBD product in the United States. It treats seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients 1+ years old. No other CBD product is FDA-approved for any medical condition (FDA, 2025).

Drug Interactions: What to Watch For

This is the most under-discussed aspect of CBD. CBD inhibits several liver enzymes (CYP2C19, CYP2C9, CYP3A4) that metabolize many common medications. A 2024 systematic review of 603 patients found that 58% of documented drug interaction cases involved unexpected medication serum levels (Frontiers in Pharmacology, 2024).

Documented increases in medication levels when combined with a 640mg daily CBD dose:

• Omeprazole (acid reflux): levels increased 207%
• Losartan (blood pressure): levels increased 77%
• Midazolam (sedation): levels increased 56%

(Clinical Pharmacology & Therapeutics, 2023)

High-risk medications to watch:

• Blood thinners (warfarin): a published case saw INR rise from about 2.2 to 6.9 on high-dose prescription CBD, requiring a warfarin dose cut (case report, 2017)
• Anti-seizure drugs (valproate, clobazam)
• Immunosuppressants (tacrolimus, sirolimus), 46% of transplant patients taking CBD/THC suffered adverse events related to medication toxicity
• Sedatives and benzodiazepines
• Some antidepressants (ask your pharmacist which ones share these enzyme pathways)

If you take any prescription medication, talk to your doctor or pharmacist before starting CBD. This isn't a disclaimer, it's based on clinical evidence of real interactions.

The Label Accuracy Problem

A 2024 analysis of 202 CBD products found that 74% deviated from their label claims by more than 10% (Frontiers in Pharmacology, 2024):

• 46% contained more CBD than the label claimed
• 28% contained less CBD than claimed, so you are not getting what you paid for
• 26% did not match their stated type, usually because they lacked the other cannabinoids the label implied; 3 of 28 broad-spectrum products contained THC
• 22% contained heavy metals (lead most prevalent)
• 90% had residual solvents detected
• 15% had pesticides

A separate 2025 analysis found that 70% of CBD gummy products had concentrations significantly different from labels (NORML, 2025).

This is why buying from dispensaries that verify COAs matters. See our COA reading guide for exactly what to look for.

Where to Buy CBD Oil in the Triangle

Most dispensaries in the Triangle directory carry CBD products. For CBD-specific shopping:

• Trek CBD in Raleigh, Education-focused CBD specialty shop, ideal for first-time buyers
• Emerald Medicine Company in Durham, Wellness-focused approach with knowledgeable staff
• The Hemp Store in Chapel Hill, Woman- and minority-owned since 2017, with a strong CBD selection
• Modern Apotheca in Raleigh, Free delivery, good CBD tincture selection
• CBD American Shaman in Durham, CBD-focused shop with oils, edibles and vapes

For shops in your area, browse by city: Raleigh, Durham, Chapel Hill, Cary.

The December 2026 Federal Question

P.L. 119-37 (signed November 2025) redefines hemp based on total THC and adds a 0.4mg total THC per container cap, effective December 11, 2026 for nearly every product. For CBD products specifically:

• CBD isolate products: Likely unaffected (zero THC)
• Broad-spectrum CBD: Likely unaffected if truly THC-free, so check the COA
• Full-spectrum CBD: Products with more than 0.4mg THC per container become federally restricted. Most full-spectrum tinctures currently on the market would exceed this threshold.

Update, October 10, 2026: The federal hemp deadline referenced below has shifted. H.R. 6500 became Public Law 119-103 on September 2, 2026, and its Section 2019 delays most of the new hemp definition, including the 0.4mg per container THC cap and the total-THC test that counts THCa, to December 11, 2026. A narrow piece covering cannabinoids the plant cannot naturally produce still begins November 12, 2026. Still current as of this update. Track it in our NC hemp bill tracker.

For the full legal context, see our guides on hemp vs. marijuana in NC and THCa legality.

---

Ready to try CBD? Browse the Triangle dispensary directory to find a shop near you, or read our guide on what to look for in a quality dispensary. For first-time buyers, our first-time dispensary guide walks through exactly what to expect.

---

This article is for informational purposes only. It does not constitute medical, legal, or product endorsement advice. CBD is not FDA-approved for any condition other than specific seizure disorders (Epidiolex). Consult a healthcare provider before starting CBD, especially if you take prescription medications. Information is current as of October 2026.